BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34399573)

  • 1. Impact of liver cirrhosis on the clinical outcomes of patients with COVID-19: a nationwide cohort study of Korea.
    Jeon D; Son M; Choi J
    Korean J Intern Med; 2021 Sep; 36(5):1092-1101. PubMed ID: 34399573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
    Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
    Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016.
    Kang C; Choi S; Jang EJ; Joo S; Jeong JH; Oh SY; Ryu HG; Lee H
    BMC Infect Dis; 2024 Feb; 24(1):184. PubMed ID: 38347513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
    Ge J; Pletcher MJ; Lai JC;
    Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
    Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.
    Jung SY; Choi JC; You SH; Kim WY
    Clin Infect Dis; 2020 Nov; 71(16):2121-2128. PubMed ID: 32442285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comorbid asthma on severity of coronavirus disease (COVID-19).
    Lee SC; Son KJ; Han CH; Jung JY; Park SC
    Sci Rep; 2020 Dec; 10(1):21805. PubMed ID: 33311519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
    Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
    United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Mortality in Elderly Coronavirus Disease 2019 Patients With Mental Health Disorders: A Nationwide Retrospective Study in South Korea.
    Lee DY; Cho J; You SC; Park RW; Kim CS; Lee EY; Aizenstein H; Andreescu C; Karim H; Hong CH; Rho HW; Park B; Son SJ
    Am J Geriatr Psychiatry; 2020 Dec; 28(12):1308-1316. PubMed ID: 33023798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.
    Jeon WH; Seon JY; Park SY; Oh IH
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32806775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study.
    Kang SH; Cho DH; Choi J; Baik SK; Gwon JG; Kim MY
    PLoS One; 2021; 16(10):e0258229. PubMed ID: 34610052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea.
    Baek MS; Lee MT; Kim WY; Choi JC; Jung SY
    PLoS One; 2021; 16(10):e0257641. PubMed ID: 34597325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study.
    Ji W; Huh K; Kang M; Hong J; Bae GH; Lee R; Na Y; Choi H; Gong SY; Choi YH; Ko KP; Im JS; Jung J
    J Korean Med Sci; 2020 Jun; 35(25):e237. PubMed ID: 32597048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic disparities in Korea by health insurance type during the COVID-19 pandemic: a nationwide study.
    Jeong HE; Lee J; Shin HJ; Shin JY
    Epidemiol Health; 2021; 43():e2021007. PubMed ID: 33445821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a comorbidity scoring system for patients with cirrhosis.
    Jepsen P; Vilstrup H; Lash TL
    Gastroenterology; 2014 Jan; 146(1):147-56; quiz e15-6. PubMed ID: 24055278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies.
    Chen TL; Lin CS; Shih CC; Huang YF; Yeh CC; Wu CH; Cherng YG; Liao CC
    BMJ Open; 2017 Oct; 7(10):e017342. PubMed ID: 28993387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.